0001600132-18-000025.txt : 20180117 0001600132-18-000025.hdr.sgml : 20180117 20180117165655 ACCESSION NUMBER: 0001600132-18-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180112 FILED AS OF DATE: 20180117 DATE AS OF CHANGE: 20180117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fernandes Peter CENTRAL INDEX KEY: 0001642618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 18532042 MAIL ADDRESS: STREET 1: PERRYVILLE III CORPORATE PARK STREET 2: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_151622620127949.xml FORM 4 X0306 4 2018-01-12 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001642618 Fernandes Peter C/O BELLEROPHON THERAPEUTICS, INC. 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 0 1 0 0 Chief Regulatory & Safety Offr Common Stock 2018-01-12 4 A 0 31527 0 A 113980 D Stock Option (right to buy) 2.03 2018-01-12 4 A 0 100000 0 A 2028-01-12 Common Stock 100000.0 100000 D This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant. /s/ Peter Fernandes 2018-01-17